Publication | Closed Access

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Anti-inflammatorySystemic TreatmentGastroenterologyClinical TrialsMaintenance TherapyPharmacotherapyUlcerative ColitisMedicineActive Ulcerative ColitisPhase 3